Site-Specific Factor 3

International Prognostic Index (IPI)

Notes

Note 1: The International Prognostic Index (IPI) has been developed for lymphomas and predicts outcome based on the following adverse factors

  • Age greater than or equal to 60 years
  • Ann Arbor Stage III or IV
  • More than 1 extranodal site involved
  • Patient's performance status (Eastern Cooperative Oncology Group, ECOG) 2, 3, or 4
  • Elevated serum lactate dehydrogenase (LDH) level

Note 2: Record the IPI as stated in the medical record. Do not calculate points or assign risk. Only record points or risk if a physician has documented them. Use points over risk if both are available.

Note 3: There are now three indices/scores associated with lymphoma

  • The International Prognostic Index (IPI) (Site-Specific Factor 3)
  • The Follicular Lymphoma International Prognostic Index (FLIPI) (Site-Specific Factor 4)
  • The International Prognostic Score (IPS- for Hodgkin lymphomas) (Site-Specific Factor 5)

Physicians may use these indices/scores interchangeably. For coding

  • Score identified: Value in appropriate SSF, 999 in other two SSFs
  • Score not identified, point value 5 or less: 999 in all three SSFs
  • Score not identified, point value 6 or 7: Value in SSF 5 (IPS), 999 in other two SSFs

Default

988

NAACCR Item

NAACCR #2900

Metadata

None
Code Description
000 0 points
001 1 point
002 2 points
003 3 points
004 4 points
005 5 points
988 Not applicable: Information not collected for this case
990 Stated as low risk (0-1 point)
991 Stated as low intermediate risk (2 points)
992 Stated as intermediate risk (3 points)
993 Stated as high risk (4-5 points)
999 Unknown or no information
Not documented in patient record